Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF

By afschroeder • March 9, 2026

Ahmed AA, Lu F, Zhang S, Raman VK, Patel SS, Morgan CJ, Faselis C, Lam PH, Fonarow GC, Heidenreich PA, Ahmad T, Anker SD, Metra M, Pitt B, Butler J, Zullo AR, Moore HJ, Vargas JD, Arundel C, Sánchez-Vallejo CA, Deedwania P, Sheriff HM, Zeng-Treitler Q, Wu WC, Ahmed A. Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF. Eur J Heart Fail. 2026 Mar 9:xuag076. doi: 10.1093/ejhf/xuag076. Epub ahead of print. PMID: 41797492.

Tags: Cardiology/Epi, Publications

Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR

Pogosyan A, Liu Y, Patel JA, Mahmoudi M, Xu H, Finn JP, Nguyen KL. Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR. Curr[...]

A New Frontier in Heart Failure: Promise and Pitfalls of Primary Prevention

Song MR, Ziaeian B. A New Frontier in Heart Failure: Promise and Pitfalls of Primary Prevention. JACC Heart Fail. 2026 Oct 28:103489. doi: 10.1016/j.jchf.2026.103489. Epub[...]

Prostate-Specific Membrane Antigen PET/CT Complements MRI for Focal Therapy Selection in Prostate Cancer: A Whole-Mount Histopathologic Study

Sonni I, Mohammadigoldar Z, Furey G, Kimura K, Movva PC, Holzgreve A, Bahri S, Sevco T, Chung A, Sisk A, Grogan T, Czernin J, Sung[...]